The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
–
About 85% of primary care patients said they’d take a blood test that looks for the toxic proteins linked to Alzheimer’s, according to a report published April 15 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
These patients said they were interested even though nearly 3 out of 4 (73%) said they expect a positive test would cause them emotional distress. That’s because anxiety over Alzheimer’s can be overwhelming, lead researcher Andrea Russell, a psychologist at Northwestern University in Chicago, said in a news release.
–
Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School of Medicine, joins Lisa Dent to discuss the recall of Xanax, the popular anxiety medication.
–
Of the many age-related problems that pose a risk to adults in midlife and beyond, so-called vestibular and balance disorders can be especially dangerous—and joy-depriving—because they increase the risk of falls and fractures and can lead people to restrict their own movement for fear of triggering another episode.
According to research at Northwestern University, vertigo and dizziness account for about one in 30 emergency-room visits, and the average patient is just over 50 years old.
–
Risk for most cardiovascular disease builds over years and often over decades. Yet we seem to be caught off guard when it happens; these heart events are often viewed as sudden or unexpected. What if we could, years or decades before, predict the likelihood that a cardiovascular event may happen? In fact, we can: the science, data, and tools are now available to do just this.
Written by Dr. Sadiya S. Khan, cardiologist and epidemiologist at the Northwestern University Feinberg School of Medicine.
–
As of October 2025, the most recent month where preliminary data is available from CDC, roughly 71,542 people had died in the U.S. over a 12-month period. That’s down dramatically from the 12-month peak of nearly 113,000 drug deaths recorded in August 2023.
“This is unprecedented and historic, for the longest consecutive months of decline,” said Lori Ann Post, a researcher at Northwestern University whose new paper in the American Journal of Public Health tracks the steady improvement. “That is awesome.”
–
A new drug is offering hope and time for patients and their families and doubling the survival rate for one of the most deadly cancers.
Dr Deva Mahalingam is a Northwestern Medicine Oncologist. “There’s no real screening tool for pancreatic cancer, and so when it starts causing symptoms, typically patients come in with weight loss, abdominal pains, sometimes jaundice, the cancer is already more advanced,” Mahalingam said.
–
Pancreatic tumors have traditionally not responded well to immunotherapies because the tumors tend to be full of fibrotic tissues that make it difficult for immune cells to infiltrate.
“We started seeing immune-cell infiltration around the tumor when we treated with the drug,” says Dr. Devalingam Mahalingam, associate director of clinical research at Northwestern University’s comprehensive cancer center and lead author of the study.
–
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about physician burnout and everything that Northwestern does to deal with employee wellness, the challenge of getting people the right care at the right place in a timely manner, COVID being down, the flu season being over, and new research that shows the flu vaccine that is recommended for older adults could lower Alzheimer’s risk.
–
Most of us wake up a few times throughout the night and quickly fall asleep again, explains Dr. Kuljeet K. Gill, sleep medicine specialist at Northwestern Medicine. These normal “microarousals” are typically inconsequential and forgotten by the following morning.
Engaging in certain activities during those nighttime wakings, however, can trick your brain into thinking you should be alert, and that your day has begun.
–
Direct-to-consumer blood testing is a growing industry targeting health-conscious patients who want to order their own blood work for the price of a dinner out. But it also can leave patients to reckon with stressful information they don’t know what to make of — and receive either a worrying result that not require action, or a false reassurance of a clean bill of health.
“Patients are getting outside testing done and bringing them to appointments asking us to interpret them for them,” Dr. Jeffrey Linder, chief of general internal medicine at Northwestern University’s Feinberg School of Medicine, said in an email.